期刊文献+

扩张型心肌病患者血清sFas、sFasL及sIL-2R水平临床意义的探讨

Clinical significance of serum levels of soluble Fas、soluble Fas ligand and soluble Ⅱ-2 receptor in patients with dilated cardiomyopathy
下载PDF
导出
摘要 目的探讨血清sFas、sFasL和sIL-2R水平与扩张型心肌病(DCM)之间的关系。方法应用酶联免疫吸附双抗体夹心(ELISA)方法,测定30例DCM患者(DCM组)和22例对照组患者的血清可溶性Fas(sFas)、可溶性Fas配体(sFasL)和可溶性白细胞介素2受体(sIL-2R)水平。结果血清sFas和血清sIL-2R平均水平,DCM组[(1718.50±119.57)ng/L、(855.00±78.03)ng/L]明显高于对照组[(1259.74±143.22)ng/L、(632.64±94.82)ng/L],有显著性差异。在DCM组中,血清sFas和血清sIL-2R平均水平随其心功能分级(NYHA分级I~IV)升高而增高。DCM组sFasL平均水平[(165.31±138.99)ng/L]与对照组[(169.85±149.63)ng/L]比较无显著性差异。DCM组血清sFas水平与sIL-2R水平存在显著正相关。结论DCM患者血清sFas、sIL-2R水平明显升高,提示其与DCM有关。血清sFas可能通过维持自身免疫炎性反应促进心肌细胞凋亡而导致DCM的发生发展。 Objective To evaluate the relationship between serum levels of soluble Fas.soluble Fas ligand and solub IL-2 receptor, and dilated cardiomyopathy (DCM). Methods By specific enzyme-linked immunosorbent assay (ELISA)tests, soluble Fas .soluble Fas ligand and soluble IL-2 receptor were measured in the sera of 30 patients with DCM (DCM group),and 22 controls (Control group). Results Mean levels of soluble Fas and soluble IL-2 receptor were significantly higher in patients with DCM than those in controls(P〈0.01). Compared with Control group, the mean level of soluble FasL was lower in DCM group, but the difference was not significant. Mean levels of soluble Fas and soluble IL-2 receptor were elevated parallel with the grades of heart function (NYHA Grade Ⅰ-Ⅳ). Moreover, soluble Fas and soluble IL-2 receptor were positively correlated in patients with DCM(r=0.441, P〈0.05). Conclusions Our study demonstrates that levels of soluble Fas and soluble IL-2 receptor in patients with DCM are elevated, which suggests that they may relate to DCM. Serum soluble Fas may facilitate pathogenesis of DCM by perpetuating autoimmune-inflammatory reactions and cardiomyocyte apoptosis.
出处 《北京医学》 CAS 2007年第3期142-144,共3页 Beijing Medical Journal
关键词 可溶性FAS 可溶性白细胞介素2受体 细胞凋亡 扩张型心肌病 Soluble Fas Soluble IL-2 receptor Cell apoptosis Dilated cardiomyopathy
  • 相关文献

参考文献12

  • 1Adamopooulos S,Parissis JT,Georgiadis M,et al.Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy.Am Heart J,2002,144:359-364.
  • 2Jeremias I,Kupatt C,Martin-Villalba A,et al.Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia.Circulation,2000,102:915-920.
  • 3Ju SF,Panka DJ,Rothstein A,et al.Fas (CD95)/FasL interaction required for programmed cell death after T-cell activation.Nature,1995,373:444-448.
  • 4Rubin LA,Nelson DL.The soluble interleukin-2 receptor:Biology,function,and clinical application.Ann Intern Med,1990,113:619-627.
  • 5Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/ International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies.Circulation,1996,93:841-842.
  • 6Schwartzman RA,Cidlowski JA.Apoptosis:the biochemistry and molecular biology of programmed cell death.Endoer Rev,1993,14:133-151.
  • 7Saraste A,Pulkki K,Kallajoki M,et al.Apoptosis in human acute myocardial infarction.Circulation,1997,95:320 -323.
  • 8Beranek JT.Cardiomyocyte apoptosis contributes to the development of catacholamine cardiomyopathy.Clin Chim Acta,2001,308:183-186.
  • 9Suda T,Okazaki T,Naito Y,et al.Expression of the Fas ligand in cells of T cell lineage.J Immunol,1995,154:3806-3813.
  • 10Ju ST,Matsui K,Ozdemirli M.Molecular and cellular mechanisms regulating T and B cell apoptosis through Fas/FasL interaction.Int Rev Immunol,1999,18:485-513.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部